Barclays Lowers Aspen Aerogels (NYSE:ASPN) Price Target to $4.00

Aspen Aerogels (NYSE:ASPN) had its price target lowered by analysts at Barclays from $6.00 to $4.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has an “underweight” rating on the construction company’s stock. Barclays‘s price objective would indicate a potential upside of 4.03% from the stock’s previous close.

ASPN has been the topic of several other research reports. Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Weiss Ratings reiterated a “sell (d)” rating on shares of Aspen Aerogels in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $12.67.

Aspen Aerogels Stock Performance

Shares of NYSE ASPN opened at $3.85 on Friday. The company has a market cap of $316.67 million, a PE ratio of -1.01 and a beta of 2.85. Aspen Aerogels has a 12 month low of $3.70 and a 12 month high of $17.56. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. The company has a 50-day simple moving average of $7.29 and a 200-day simple moving average of $6.77.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, November 6th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The firm had revenue of $73.02 million for the quarter, compared to analysts’ expectations of $73.42 million. During the same period in the previous year, the company posted ($0.17) EPS. The business’s quarterly revenue was down 37.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, equities analysts anticipate that Aspen Aerogels will post 0.17 earnings per share for the current year.

Insider Buying and Selling

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the firm’s stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the transaction, the chief accounting officer directly owned 19,879 shares in the company, valued at $145,315.49. This trade represents a 18.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. grew its stake in Aspen Aerogels by 6.8% during the second quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock worth $157,000 after buying an additional 1,687 shares during the period. Alps Advisors Inc. lifted its holdings in shares of Aspen Aerogels by 1.7% during the 1st quarter. Alps Advisors Inc. now owns 126,326 shares of the construction company’s stock valued at $807,000 after acquiring an additional 2,093 shares in the last quarter. Legal & General Group Plc boosted its position in Aspen Aerogels by 3.6% during the 2nd quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock worth $397,000 after purchasing an additional 2,324 shares during the period. Osaic Holdings Inc. boosted its position in Aspen Aerogels by 29.1% during the 2nd quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock worth $63,000 after purchasing an additional 2,390 shares during the period. Finally, SBI Securities Co. Ltd. increased its holdings in Aspen Aerogels by 67.3% in the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock valued at $38,000 after purchasing an additional 2,551 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.